Schott Pharma AG KGaASHTPY -42.88%64 PEG Ratio is 0.92 as of Jul. 01, 2026, which is 20% below its 10-year median of 1.15. GuruFocus rates SHTPY with a GF Score™ of 64/100 and a GF Value™ of $7.02. The stock has 2 warning signs investors should review. Among 207 Medical Devices & Instruments companies, Schott Pharma AG KGaA ranks better than 71.5% on this metric.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Schott Pharma AG KGaA's PEG Ratio or its related term are showing as below:
SHTPY'
s PEG Ratio Range Over the Past 10 Years
Min: 0.9 Med: 1.15 Max: 1.3
Current: 1.07
During the past 6 years, Schott Pharma AG KGaA's highest PEG Ratio was 1.30. The lowest was 0.90. And the median was 1.15.
SHTPY's PEG Ratio is ranked better than 71.5% of 207
companies
in the Medical Devices & Instruments industry
Industry Median: 2.03
vs SHTPY: 1.07
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Schott Pharma AG KGaA (OTCPK:SHTPY) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Schott Pharma AG KGaA's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Schott Pharma AG KGaA PEG Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Schott Pharma AG KGaA's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Schott Pharma AG KGaA's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Schott Pharma AG KGaA (SHTPY) has a PEG Ratio of 0.92 as of Jul. 01, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Schott Pharma AG KGaA and its competitors. This is 20% below median its historical median of 1.15. Over the past decade, Schott Pharma AG KGaA's PEG Ratio has ranged from 0.90 to 1.30. According to the industry distribution chart, Schott Pharma AG KGaA ranks #59 out of 207 companies in the Medical Devices & Instruments industry, placing it in the top 28.5%.
Is Schott Pharma AG KGaA's PEG Ratio too high?
Schott Pharma AG KGaA's current PEG Ratio of 0.92 is 20% below median its 10-year median of 1.15. Over the past 10 years, this metric has ranged from a low of 0.90 to a high of 1.30. The Medical Devices & Instruments industry median PEG Ratio is 2.03. Schott Pharma AG KGaA's value of 0.92 is 54.7% below this industry median. Based on the distribution chart, Schott Pharma AG KGaA ranks #59 out of 207 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Schott Pharma AG KGaA has a GF Score™ of 64/100, reflecting its overall financial health beyond just this single metric.
How does Schott Pharma AG KGaA's PEG Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Schott Pharma AG KGaA ranks #59 out of 207 companies for PEG Ratio. This puts Schott Pharma AG KGaA in the upper half of its industry. The industry median PEG Ratio is 2.03. Schott Pharma AG KGaA's value of 0.92 is 54.7% below this benchmark. Historically, Schott Pharma AG KGaA's own PEG Ratio has ranged from 0.90 to 1.30 over the past decade. While the company's 10-year median is 1.15 vs. the industry median of 2.03, Schott Pharma AG KGaA has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Medical Devices & Instruments company?
The median PEG Ratio among Medical Devices & Instruments companies is 2.03, based on 207 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Schott Pharma AG KGaA's current PEG Ratio of 0.92 is 54.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Schott Pharma AG KGaA and its competitors. For the Medical Devices & Instruments industry, the median PEG Ratio is 2.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Schott Pharma AG KGaA's current PEG Ratio is 0.92, which is 20% below median its own 10-year median of 1.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Schott Pharma AG KGaA stock overvalued right now?
Schott Pharma AG KGaA (SHTPY) has a current PEG Ratio of 0.92. The stock's GF Value™ is $7.02, compared to a current price of $4.37 — trading 37.7% below its estimated fair value. The current PEG Ratio is 0.92, which is 20% below median its 10-year median of 1.15 and 54.7% below the Medical Devices & Instruments industry median of 2.03. Schott Pharma AG KGaA's overall GF Score™ is 64/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For Schott Pharma AG KGaA (SHTPY), the current PEG Ratio is 0.92 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Schott Pharma AG KGaA (SHTPY) Overvalued in 2026?
Based on GuruFocus' analysis, Schott Pharma AG KGaA stock appears to be undervalued.
The current stock price of $4.37 is trading 37.7% below its estimated GF Value™ of $7.02.
Key valuation signals for SHTPY:
PEG Ratio: 0.92 (20% below median its 10-year median of 1.15)
GF Value™: $7.02 vs. price of $4.37 (37.7% below fair value)
Industry Position: 54.7% below the Medical Devices & Instruments median (#59 of 207)
No single metric tells the full story. See the SHTPY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Schott Pharma AG & CO KGaA is an international provider of drug containment solutions and delivery systems for injectable drugs for pharma, biotech and life-sciences. Its business operates in two segments: Drug Containment Solutions (DCS) and Drug Delivery Systems (DDS). The majority of revenue is being generated from the DCS segment, which includes products like vials, cartridges, and ampoules, and provides customers with sterile and non-sterile options in standard and high-end formats for drug storage. Geographically, the company generates revenue from Europe, the Middle East, Africa (EMEA), Asia and the South Pacific, North America, and South America.
64GF Score
Get the complete analysis for SHTPY
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHTPY has been successfully added to your 
